Jay Venkatesan

REVA Medical, Inc. engages in the development and commercialization of medical devices. It focuses on polymer-based bioresorbable products for vascular applications. The company was founded by Robert Bernard Stockman on June 3, 1998 and is headquartered in San Diego, CA.

Varro Technologies, Inc. develops distributed knowledge management applications for the life science industry. It offers a patent-pending technology solution for accessing, managing, and sharing the genetic information. The company was founded by Jay Venkatesan, David Sullivan Shin, Wesley Chan, and Chester M Hedgepeth III on December 22, 2000 and is headquartered in Philadelphia, PA.

ACM Capital Partners LLC provides investments services. The company is headquartered in Miami, FL.

Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL.

Alpine Biosciences, Inc. provided research and development of protocells for treatment of rare diseases and cancer. The company was headquartered in Seattle, WA.

Targanta Therapeutics Corp. discovers and develops novel antibacterial pro drugs. The company was founded in 1997 and is headquartered in Parsippany, NJ.

Alpine Immune Sciences, Inc. operates as a biotechnology company which develops cancer immunotherapy systems. The firm provides immunotherapy and immune synapse solutions. The company was founded by Ryan Swanson and Michael Kornacker in 2015 and is headquartered in Seattle, WA.

Cascadian Therapeutics LLC is a clinical-stage biopharmaceutical company, which focuses on the development of therapeutic products for the treatment of cancer. Its product ONT-380, is an orally active and selective small-molecule HER2 inhibitor. The firm also develops preclinical product candidates in oncology using Chk1 kinase inhibitor and protocell technology. The company was founded on September 7, 2007 and is headquartered in Bothell, WA.

Tangerine Technologies, Inc. provides software development and business process outsourcing solutions. The company was founded by Jay Venkatesan and Todd Riley Johnson in 1999 and is headquartered in Santa Clara, CA.

Transplant Genomics, Inc. operates as a molecular diagnostic company. It develops molecular diagnostic tests that detect early signs of graft injury, differentiate among actionable causes and enable optimization of therapy. The company was founded by Daniel Salomon in 2013 and is headquartered in Mansfield, MA.

Cell Biotherapy, Inc. develops bio therapeutics. The American company was founded by Michael E. Meyers and he has been the CEO since incorporation.

Angion Biomedica Corp. operates as a biopharmaceutical company. The firm focuses on the discovery and development of novel therapeutic agents to address acute organ injuries and fibrotic diseases. Its product pipeline includes ANG-3777, ANG-3070, ROCK2 Inhibitor and CYP11B2 Inhibitors. The company was founded by Itzhak D. Goldberg on April 6, 1998 and is headquartered in Newton, MA.

Tivorsan Pharmaceuticals, Inc. is a protein therapeutics firm. It develops products to treat Duchenne Muscular Dystrophy (DMD) and Becker Muscular Dystrophy (BMD). The company was founded by Justin Fallon and Joel Bennett Braunstein and is headquartered in Providence, RI.

Alpine Bioventures, GP, LLC (Alpine Bioventures) is a venture capital firm founded by Mitchell H. Gold in 2013. The firm is headquartered in Seattle, Washington.

Alpine Bioventures LP invests in companies located in the United States. The fund targets companies operating in the fields of science and healthcare services. It provides financing for seed and early stage capital requirements. It also makes co-investments.

Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA.